in pictures and a few words
What it is and why it matters
In fatty liver disease, extra fat builds up in the liver. There are many “liver” supplements, but only three have been tested in serious studies in people with this disease.
- Vitamin E
- Silymarin — a substance from milk thistle
- Acetylcysteine
The main step: lose weight
Losing 7–10% of body weight helps the liver more than any supplement. In people who did this, the disease in the liver receded — it was visible in the liver tissue itself.
- This is where you start
- Supplements add to it, they don’t replace it
Vitamin E: the strongest result
In people without diabetes who had inflammation in a fatty liver, vitamin E improved the liver tissue itself over almost two years. This was checked with a tiny piece of the liver.
- It was studied specifically in people without diabetes
- Whether you need it and how long to take it is up to your doctor
Silymarin from milk thistle
Silymarin is a mix of substances from milk thistle. In people with inflammation in a fatty liver but no cirrhosis — severe scarring of the liver — it improved liver tests over about a year.
- In the study: 700 mg three times a day
- It is taken instead of vitamin E or together with it
Acetylcysteine
The body makes the liver’s main protective substance from acetylcysteine. In a small study in people with fatty liver, a liver test and spleen size fell more over three months than with vitamin C.
- In the study: 600 mg twice a day
- It is taken if other options didn’t suit you, or together with them
Tests come first
Before taking supplements, the liver is checked. Without this check, supplements make no sense.
- Blood tests for the liver
- A calculation from the tests: is there scarring in the liver
- If the calculation is unclear — a machine check of liver stiffness
Check again in 3–6 months
Supplements aren’t taken blindly: after a few months, the liver is checked again.
- Silymarin — liver tests after 8–12 weeks
- Vitamin E — a check after 3–6 months
- Then tests again and, if possible, a liver stiffness check
Vitamin E is not “just in case”
No one has shown a benefit from taking it longer than in the study. So vitamin E isn’t taken on your own and with no end date.
- How long to take it is decided with a doctor
Important. In other groups of people, long-term use of more than 400 IU of vitamin E a day was linked to a slightly higher risk of death and of bleeding stroke.
Who should see a doctor first
Before any liver supplements, discuss the plan with a doctor. Especially if you have diabetes, take blood-thinning medicines, or plan to take them for more than a few months.
- The liver test ALT stays above 30 U/L in men or 19 U/L in women
- …and this isn’t explained by alcohol or viral hepatitis
- If the scarring estimate is unclear — a machine check comes before supplements
Important. If fatty liver disease is confirmed and you have obesity, diabetes or unhealthy blood fats — supplements are chosen together with a doctor.
In one sentence
The main thing for the liver is losing weight. Vitamin E, silymarin and acetylcysteine have been tested in people with this disease — they are chosen with a doctor after tests.
Key points
In fatty liver disease (MASLD/NAFLD, metabolic dysfunction-associated steatotic liver disease), controlled trials exist for three substances — vitamin E, silymarin, and N-acetylcysteine (NAC). The largest proven effect comes from weight loss.
| Ingredient | Amount per serving | How it is useful | What human studies showed |
|---|---|---|---|
| Vitamin E | 800 IU per day, 96 weeks | the only one of the three with a biopsy-confirmed effect on the liver | in the PIVENS RCT in people without diabetes with biopsy-confirmed NASH — the only arm to meet the primary histologic endpoint (PMID 20427778[1]) |
| Silymarin (milk thistle) | 700 mg 3 times a day (2100 mg), 48 weeks | a complex of six major flavonolignans from milk thistle | in a double-blind placebo-controlled RCT in people with NASH without cirrhosis — improved laboratory markers (PMID 28419855[2]) |
| NAC (N-acetylcysteine) | 600 mg twice a day, 3 months | a precursor to glutathione, the liver's key antioxidant | in 30 patients with fatty liver disease, significantly reduced ALT and spleen size compared with vitamin C (PMID 22308119[3]) |
| Weight loss | 7–10% | first-line intervention | histologically regresses NASH — a larger effect than any supplement (Vilar-Gomez 2015, PMID 25865049[4]) |
How each substance helps
Vitamin E
The PIVENS trial (Pioglitazone versus Vitamin E versus Placebo, N Engl J Med 2010;362:1675–1685, PMID 20427778[1]) was a randomized placebo-controlled trial in non-diabetic patients with biopsy-confirmed NASH. Vitamin E at 800 IU/day for 96 weeks was the only arm to meet the prespecified primary histologic endpoint — improvement on a strict liver histology scoring system.
Silymarin (milk thistle)
Silymarin is a complex of six major flavonolignans from milk thistle (Silybum marianum). A randomized double-blind placebo-controlled trial in non-cirrhotic NASH patients (Clin Gastroenterol Hepatol, PMID 28419855[2]) used silymarin 700 mg three times daily (2100 mg/day) for 48 weeks and showed improved laboratory markers.
N-acetylcysteine (NAC)
NAC is a precursor to glutathione, the liver's key antioxidant. A controlled trial (Khoshbaten M, et al., Hepat Mon, PMID 22308119[3]) compared NAC 600 mg twice daily to vitamin C 1000 mg twice daily in 30 patients with fatty liver disease over 3 months. NAC significantly reduced ALT and spleen size compared to vitamin C.
How to take
- Baseline diagnostics: ALT, AST, FIB-4 (see ALT without symptoms: silent liver diseases) — supplements without a baseline fibrosis assessment are not meaningful.
- 7–10% weight loss — first line.
- Vitamin E 800 IU/day — discuss with a physician for confirmed NASH without diabetes, recheck at 3–6 months.
- Silymarin 2100 mg/day (700 mg×3) — an alternative or addition, recheck ALT/AST at 8–12 weeks.
- NAC 600 mg twice daily — for intolerance to other options or as an addition.
- Recheck at 3–6 months — ALT, AST, and FibroScan if available.
Who should see a doctor first
Discuss any nutraceutical plan with your treating physician before starting, especially with diabetes, anticoagulant use, or planned use beyond a few months.
- Vitamin E is not a "just in case" supplement. Long-term high-dose vitamin E (>400 IU/day) has been associated in other populations with a small increase in all-cause mortality and hemorrhagic stroke risk. PIVENS does not support benefit from continuing beyond the studied protocol: the duration is decided with a physician, not self-extended indefinitely.
- ALT persistently above 30 U/L (men) / 19 U/L (women) not explained by alcohol or viral hepatitis.
- Confirmed MASLD/NASH with metabolic risk factors (obesity, diabetes, dyslipidemia) — discuss vitamin E, silymarin, or NAC as part of a comprehensive protocol.
- FIB-4 in the gray zone (1.3–2.67) — referral for FibroScan before choosing supplements.
Bottom line
Controlled data in fatty liver disease exists for three substances: vitamin E 800 IU/day (the strongest evidence base, biopsy-confirmed, in people without diabetes), silymarin 2100 mg/day, and NAC 600 mg twice daily (real RCTs of smaller scale). None replaces 7–10% weight loss — the intervention with the largest proven effect on the liver.
I assess fatty liver disease stage (ALT, AST, FIB-4, FibroScan referral when indicated) and build a protocol based on actual trial evidence, not marketing claims.
References
Key facts
- Three substances have RCT data in fatty liver disease: vitamin E, silymarin, and NAC.
- Vitamin E 800 IU/day for 96 weeks (PIVENS) — the only agent with biopsy-confirmed NASH improvement in people without diabetes.
- Silymarin 700 mg×3 (2100 mg/day) for 48 weeks improved lab markers in a placebo-controlled RCT in people with NASH without cirrhosis.
- NAC 600 mg twice daily for 3 months (n=30) reduced ALT and spleen size versus vitamin C.
- 7–10% weight loss histologically regresses NASH (Vilar-Gomez 2015) — a larger effect than any supplement.




